Stericycle, Inc. (SRCL)

Check out top investors' recommendation for SRCL
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
79.00
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
67%/33%
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
Stericycle, Inc., together with its subsidiaries, provides regulated waste management and related services. It offers institutional Steri-Safe medical waste and compliance program; Bio Systems reusable sharps management services to reduce the risk of needle sticks; pharmaceutical and hazardous waste disposal services; and integrated waste stream solutions program. The company also provides various products and services for infection control; regulated recall and returns management services for expired or recalled products and pharmaceuticals; various patient communication services; and Steri-Safe OSHA and HIPAA compliance, and clinical services programs. Stericycle, Inc. serves large-quantity generators of regulated waste, such as hospitals, blood banks, and pharmaceutical manufacturers; and small-quantity generators of regulated waste comprising outpatient clinics, medical and dental offices, long-term and sub-acute care facilities, veterinary offices, municipalities, and retail pharmacies. It operates in the United States, Argentina, Brazil, Canada, Chile, Ireland, Japan, Mexico, Portugal, Romania, Spain, and the United Kingdom. The company was founded in 1989 and is headquartered in Lake Forest, Illinois.
Industry:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Michael Hoffman Wunderlich Securities, Inc. Buy   Dec 28, '17     85.00  Dec 28, '18  N/A 
Gary Bisbee Barclays Sell   Nov 09, '17     67.00  Nov 09, '18  N/A 
Michael Hoffman Wunderlich Securities, Inc. Buy   Nov 09, '17     85.00  Nov 09, '18  N/A 
Michael Hoffman Wunderlich Securities, Inc. Buy   Aug 13, '17     95.00  Aug 13, '18  N/A 
Gary Bisbee Barclays Sell   Aug 04, '17     74.00  Aug 04, '18  N/A 
David Windley Jefferies & Co. Buy   Jul 07, '17     108.00  Jul 07, '18  N/A 
Gary Bisbee Barclays Sell   Jun 26, '17     74.00  Jun 26, '18  N/A 
David Manthey Robert W. Baird & Co., Inc. Sell   May 05, '17     73.00  May 05, '18  N/A 
Kevin Steinke Barrington Research Buy   Feb 22, '17     93.00  Feb 22, '18  N/A 
Gary Bisbee Barclays Sell   Jan 20, '17     74.00  Jan 20, '18  N/A 
Isaac Ro Goldman Sachs Sell   Nov 03, '16       Nov 03, '17  N/A 
Michael Hoffman Wunderlich Securities, Inc. Buy   Oct 28, '16     90.00  Oct 28, '17  N/A 
Kevin Steinke Barrington Research Buy   Oct 05, '16     88.00  Oct 05, '17  N/A 
Ryan Daniels William Blair & Company, L.L.C. Buy   Oct 09, '15   148.63    Oct 09, '16  -49.47% 
William Fisher Raymond James Buy   Sep 08, '15   145.61    Sep 08, '16  -43.14% 
Scott Schneeberger Oppenheimer & Co. Buy   Oct 24, '14   123.05  130.00  Oct 24, '15  5.65% 
David Manthey Robert W. Baird & Co., Inc. Buy   Jun 13, '14   118.47  140.00  Jun 13, '15  18.17% 
Kevin Steinke Barrington Research Buy   Apr 28, '14   115.25  131.00  Apr 28, '15  17.19% 
Isaac Ro Goldman Sachs Buy   Apr 11, '14   109.33  129.00  Apr 11, '15  29.82% 
Michael Hoffman Wunderlich Securities, Inc. Buy   Jan 13, '14   115.02  140.00  Jan 13, '15  15.04% 
< previous12